Back
Sol Strategies Vs. Monopar Therapeutics Industry Stock Comparison
Buy
82
HODL.CX
Sol Strategies
Last Price:
1.3500
Seasonality Move:
36.68%
Buy
65
MNPR
Monopar Therapeutics
Last Price:
34.14
Seasonality Move:
7.43%
Buy
82
Sol Strategies (HODL.CX)
is a Buy
Is Sol Strategies a Buy, Sell or Hold?
- The current Sol Strategies [HODL.CX] share price is $1.3500. The Score for HODL.CX is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- HODL.CX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
65
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
- The current Monopar Therapeutics [MNPR] share price is $32.66. The Score for MNPR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- MNPR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HODL.CX Stock Price Chart
What is Sol Strategies's stock price today?
-
The Sol Strategies share price today is $1.3500
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HODL.CX is experiencing slight selling pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $32.66
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
HODL.CX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 95.58 | Buy |
| Chaikin Money Flow: | -113353 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.1018 - 0.7418) | Buy |
| Bollinger Bands (100): | (0.0144 - 0.4144) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.46 | Buy |
| Relative Strength Index (14 RSI): | 93.57 | Buy |
| Chaikin Money Flow: | 12436621 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.85 - 11.69) | Buy |
| Bollinger Bands (100): | (0.99 - 7.11) | Buy |
HODL.CX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.82 | Buy |
| 20-day SMA: | 0.48 | Buy |
| 50-day SMA: | 0.29 | Buy |
| 200-day SMA: | 0.17 | Buy |
| 8-day EMA: | 0.89 | Buy |
| 20-day EMA: | 0.6 | Buy |
| 50-day EMA: | 0.38 | Buy |
| 200-day EMA: | 0.2 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.64 | Buy |
| 20-day SMA: | 6.69 | Buy |
| 50-day SMA: | 4.51 | Buy |
| 200-day SMA: | 3.61 | Buy |
| 8-day EMA: | 11.25 | Buy |
| 20-day EMA: | 7.63 | Buy |
| 50-day EMA: | 5.48 | Buy |
| 200-day EMA: | 4.09 | Buy |
Sol Strategies Earnings Growth & HODL.CX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.34 per share, and a decrease next year of $0.21 per share.
Sol Strategies Technical Analysis
| Oct 9 | Oct 10 | Oct 11 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 09 | 10 | 11 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics Technical Analysis
| Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||